Lumen Bioscience names chief medical officer after $16M Series B

Seattle-based Lumen Bioscience hired a chief medical officer from outside the Puget Sound region after recording a $16 million Series B earlier this month. The biotech announced last week that it’s brought on Mike Spirgarelli, who will be leading the company’s clinical development operations. To date, Lumen has raised $68 million between equity and non-dilutive investments to support its three clinical programs for C. difficile, norovirus and t raveler’s diarrhea. Lumen’s lead candidate…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news